Showing results (21-30 of 364) with videos related to
Sort By:
Pageof 37
Toxins|May 12, 2017
Mitigation of Patulin in Fresh and Processed Foods and BeveragesJ David Ioi, Ting Zhou, Rong Tsao, et al.Journal of Medicinal Food|December 17, 2013
Antioxidant capacity of food mixtures is not correlated with their antiproliferative activity against MCF-7 breast cancer cellsSunan Wang, Fan Zhu, Kelly A Meckling, et al.Canadian Respiratory Journal|May 6, 2005
Endobronchial mimics of primary endobronchial carcinoma: a clinical study of 25 casesCynthia M Magro, Patrick RossThe American Journal of Dermatopathology|August 19, 2025
Primary Cutaneous CD4+ Small/Medium-Sized T-Cell Lymphoproliferative Disorder: A Retrospective Cohort Study of 40 Adult PatientsXing Li, Cynthia M MagroThe American Journal of Dermatopathology|November 30, 2012
CCL5 expression in panniculitic T-cell dyscrasias and its potential role in adipocyte tropismCynthia M Magro, Xuan WangEuropean Journal of Dermatology : EJD|October 3, 2012
Human myxovirus resistance protein 1 (MxA) as a useful marker in the differential diagnosis of subcutaneous lymphoma vs. lupus erythematosus profundusXuan Wang, Cynthia M MagroJournal of Immunopharmacology|January 1, 1983
The orally active antiallergic compound, LC-6 (trans-2,3b,4,5,7,8b,9,10-octahydronaphtho[1,2-c:5,6-C] dipyrazole) inhibits the arachidonate lipoxygenase enzymeA M Magro, I HurtadoAnnals of Diagnostic Pathology|November 18, 2017
Lymphocytic thrombophilic arteritis: A distinct inflammatory type I interferon and C5b-9 mediated subcutaneous endovasculitisCynthia M Magro, Jad SaabThe American Journal of Dermatopathology|September 19, 2025
Pediatric CD4+ Small Medium Sized Pleomorphic T-cell Lymphoproliferative Disorder: A Unique Indolent Lymphoproliferative Lesion With Consistent Reproducible Clinical and Phenotypic FeaturesXing Li, Cynthia M MagroThe American Journal of Dermatopathology|August 16, 2024
Tumor necrosis factor ALPHA Inhibitor Associated Köhlmeier-Degos Disease as a Novel Iatrogenic Paradigm That Underscores Excessive Type I Interferon in Its PathogenesisCynthia M Magro, Scott SandersPageof 37